EMEA-002769-PIP01-20
Key facts
| Active substance |
human fibrinogen
|
| Therapeutic area |
Haematology-Hemostaseology
|
| Decision number |
P/0260/2020
|
| PIP number |
EMEA-002769-PIP01-20
|
| Pharmaceutical form(s) |
Powder and solvent for solution for injection
|
| Condition(s) / indication(s) |
Treatment of congenital fibrinogen deficiency
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Instituto Grifols, S.A.
E-mail: areatecnica.instituto@grifols.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|